Open AccessIs it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease?
Author(s) -
Aroon D. Hingorani,
Reecha Sofat,
Richard Morris,
Peter H. Whincup,
Gordon Lowe,
Jennifer S. Mindell,
Naveed Sattar,
J. P. Casas,
Tina Shah
Publication year - 2012
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehs168
Subject(s) - rosuvastatin , medicine , c reactive protein , placebo , rosuvastatin calcium , statin , disease , cholesterol , inflammation , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom